TrialJournal of geriatric oncology2021

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer.

Yuan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.